Safety and efficacy of eculizumab in anti-acetylcholine receptor antibodypositive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study - Howard, J F; Utsugisawa, K; Benatar, M (Lancet Neurol, 2017)